Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bicycle Therapeutics (BCYC) Change in Receivables: 2018-2023

Historic Change in Receivables for Bicycle Therapeutics (BCYC) over the last 6 years, with Dec 2023 value amounting to -$2.5 million.

  • Bicycle Therapeutics' Change in Receivables was N/A to $133,000 in Q1 2025 from the same period last year, while for Mar 2025 it was -$2.3 million, marking a year-over-year change of. This contributed to the annual value of -$2.5 million for FY2023, which is 251.25% down from last year.
  • Bicycle Therapeutics' Change in Receivables amounted to -$2.5 million in FY2023, which was down 251.25% from $1.6 million recorded in FY2022.
  • In the past 5 years, Bicycle Therapeutics' Change in Receivables ranged from a high of $2.1 million in FY2020 and a low of -$4.9 million during FY2019.
  • Its 3-year average for Change in Receivables is -$1.8 million, with a median of -$2.5 million in 2023.
  • In the last 5 years, Bicycle Therapeutics' Change in Receivables crashed by 1,327.25% in 2019 and then spiked by 143.78% in 2020.
  • Over the past 5 years, Bicycle Therapeutics' Change in Receivables (Yearly) stood at -$4.9 million in 2019, then skyrocketed by 143.78% to $2.1 million in 2020, then tumbled by 311.40% to -$4.5 million in 2021, then soared by 136.12% to $1.6 million in 2022, then crashed by 251.25% to -$2.5 million in 2023.